Back to VANGUARD GROUP INC VANGUARD GROUP INC

TNXPTNXP
4 quarters

Position history for VANGUARD GROUP INCVANGUARD GROUP INC's holdings in TONIX PHARMACEUTICALS HOLDIN

As of its last 13F, for Q4 2025, Vanguard Group held 673,605 shares of TNXP (Tonix Pharmaceuticals Holdin), worth $10.5M. It increased the position by 116,648 shares (+20.9%) from Q3 2025. Vanguard Group held TNXP from Q1 2025 to Q4 2025, across 4 quarterly 13F filings.

Current Value

$10.5M

Current Shares

673,605

Total Value Change

+$8.9M

Total Shares Change

+582,109

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q4
Latest
Increased
673,605
+20.9%
$10.5M0.0%$15.62
33
2025-Q3
Increased
556,957
+238.1%
$13.5M0.0%$24.16
45
2025-Q2
Increased
164,732
+80.0%
$5.9M0.0%$35.98
42
2025-Q1
New
91,496
-
$1.6M0.0%$17.88
39

Other major holders of TNXP: BlackRock, Inc., Point72 Asset Management, L.P.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used